These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 26542500)

  • 21. Regional differences of undiagnosed type 2 diabetes and prediabetes prevalence are not explained by known risk factors.
    Tamayo T; Schipf S; Meisinger C; Schunk M; Maier W; Herder C; Roden M; Nauck M; Peters A; Völzke H; Rathmann W
    PLoS One; 2014; 9(11):e113154. PubMed ID: 25402347
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Defining unrecognized myocardial infarction: a call for standardized electrocardiographic diagnostic criteria.
    Ammar KA; Kors JA; Yawn BP; Rodeheffer RJ
    Am Heart J; 2004 Aug; 148(2):277-84. PubMed ID: 15308997
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.
    Kim SH; Chunawala L; Linde R; Reaven GM
    J Am Coll Cardiol; 2006 Jul; 48(2):293-7. PubMed ID: 16843178
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of diabetes and prediabetes on the short-term prognosis in patients with acute ischemic stroke.
    Tanaka R; Ueno Y; Miyamoto N; Yamashiro K; Tanaka Y; Shimura H; Hattori N; Urabe T
    J Neurol Sci; 2013 Sep; 332(1-2):45-50. PubMed ID: 23810779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unrecognised myocardial infarction in subjects at high vascular risk: prevalence and determinants.
    Meijs MF; Bots ML; Cramer MJ; Vonken EJ; Velthuis BK; van der Graaf Y; Visseren FL; Mali WP; Doevendans PA;
    Heart; 2009 May; 95(9):728-32. PubMed ID: 19218261
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Location of arterial stiffening differs in those with impaired fasting glucose versus diabetes: implications for left ventricular hypertrophy from the Multi-Ethnic Study of Atherosclerosis.
    Rerkpattanapipat P; D'Agostino RB; Link KM; Shahar E; Lima JA; Bluemke DA; Sinha S; Herrington DM; Hundley WG
    Diabetes; 2009 Apr; 58(4):946-53. PubMed ID: 19136657
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Elevated level of C-reactive protein is associated with risk of prediabetes in Indians.
    Jaiswal A; Tabassum R; Podder A; Ghosh S; Tandon N; Bharadwaj D
    Atherosclerosis; 2012 Jun; 222(2):495-501. PubMed ID: 22464286
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinically unrecognized myocardial infarction detected at MR imaging may not be associated with atherosclerosis.
    Ebeling Barbier C; Bjerner T; Hansen T; Andersson J; Lind L; Hulthe J; Johansson L; Ahlström H
    Radiology; 2007 Oct; 245(1):103-10. PubMed ID: 17717330
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Impaired functional status and echocardiographic abnormalities signifying global dysfunction enhance the prognostic significance of previously unrecognized myocardial infarction detected by electrocardiography.
    Ammar KA; Makwana R; Jacobsen SJ; Kors JA; Burnett JC; Redfield MM; Yawn BP; Rodeheffer RJ
    Ann Noninvasive Electrocardiol; 2007 Jan; 12(1):27-37. PubMed ID: 17286648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study.
    Levitzky YS; Pencina MJ; D'Agostino RB; Meigs JB; Murabito JM; Vasan RS; Fox CS
    J Am Coll Cardiol; 2008 Jan; 51(3):264-70. PubMed ID: 18206734
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Influence of impaired fasting glucose on the incidence and prognosis of atherosclerosis in various vascular regions].
    Espinola-Klein C; Rupprecht HJ; Blankenberg S; Bickel C; Fossmeyer U; Kopp H; Victor A; Peetz D; Lackner K
    Z Kardiol; 2004; 93 Suppl 4():IV48-55. PubMed ID: 15085366
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lipid risk factors among elderly with normal fasting glucose, impaired fasting glucose and type 2 diabetes mellitus. The Italian longitudinal study on aging.
    Noale M; Maggi S; Zanoni S; Limongi F; Zambon S; Crepaldi G
    Nutr Metab Cardiovasc Dis; 2013 Mar; 23(3):220-6. PubMed ID: 21937208
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
    Amoah AG; Schuster DP; Gaillard T; Osei K
    Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediabetes and its relationship with obesity in Mexican adults: The Mexican Diabetes Prevention (MexDiab) Study.
    Guerrero-Romero F; Rodríguez-Morán M; Pérez-Fuentes R; Sánchez-Guillén MC; González-Ortiz M; Martínez-Abundis E; Brito-Zurita O; Madero A; Figueroa B; Revilla-Monsalve C; Flores-Martínez SE; Islas-Andrade S; Rascón-Pacheco RA; Cruz M; Sánchez-Corona J
    Metab Syndr Relat Disord; 2008 Mar; 6(1):15-23. PubMed ID: 18370832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Associated factors of impaired fasting glucose in some Korean rural adults].
    Yun HE; Han MA; Kim KS; Park J; Kang MG; Ryu SY
    J Prev Med Public Health; 2010 Jul; 43(4):309-18. PubMed ID: 20689357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Midlife Cardiovascular Risk Factors and Late-Life Unrecognized and Recognized Myocardial Infarction Detect by Cardiac Magnetic Resonance: ICELAND-MI, the AGES-Reykjavik Study.
    McAreavey D; Vidal JS; Aspelund T; Eiriksdottir G; Schelbert EB; Kjartansson O; Cao JJ; Thorgeirsson G; Sigurdsson S; Garcia M; Harris TB; Launer LJ; Gudnason V; Arai AE
    J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26873683
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment tools for unrecognized myocardial infarction: a cross-sectional analysis of the REasons for Geographic and Racial Differences in Stroke population.
    Levitan EB; Safford MM; Kilgore ML; Soliman EZ; Glasser SP; Judd SE; Muntner P
    BMC Cardiovasc Disord; 2013 Mar; 13():23. PubMed ID: 23530553
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuropathic pain in diabetes, prediabetes and normal glucose tolerance: the MONICA/KORA Augsburg Surveys S2 and S3.
    Ziegler D; Rathmann W; Dickhaus T; Meisinger C; Mielck A;
    Pain Med; 2009 Mar; 10(2):393-400. PubMed ID: 19207236
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fasting plasma glucose as initial screening for diabetes and prediabetes in irish adults: The Diabetes Mellitus and Vascular health initiative (DMVhi).
    Sinnott M; Kinsley BT; Jackson AD; Walsh C; O'Grady T; Nolan JJ; Gaffney P; Boran G; Kelleher C; Carr B
    PLoS One; 2015; 10(4):e0122704. PubMed ID: 25874867
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of metabolic syndrome, diabetes and prediabetes on cardiovascular events: Tehran lipid and glucose study.
    Hadaegh F; Shafiee G; Ghasemi A; Sarbakhsh P; Azizi F
    Diabetes Res Clin Pract; 2010 Mar; 87(3):342-7. PubMed ID: 20004035
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.